D-0551-2026 Class III Ongoing
FDA drug recall D-0551-2026 was initiated by AbbVie Inc. on May 18, 2026 and is designated Class III. Reason for recall: Failed Stability Specifications The recall status is ongoing. Affected quantity: 2,736 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 3, 2026
- Initiation Date
- May 18, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,736 bottles
Product description
PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicago, IL 60064, Product of France, NDC 11980-174-10.
Reason for recall
Failed Stability Specifications
Distribution pattern
US Nationwide.
Code information
Lot # 402805, 407596, Exp Date: 08/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0551-2026
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for AbbVie Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.